In the last trading session, 3.91 million shares of the Pliant Therapeutics Inc (NASDAQ:PLRX) were traded, and its beta was 1.41. Most recently the company’s share price was $1.55, and it changed around -$0.03 or -1.90% from the last close, which brings the market valuation of the company to $94.92M. PLRX currently trades at a discount to its 52-week high of $16.52, offering almost -965.81% off that amount. The share price’s 52-week low was $1.26, which indicates that the current value has risen by an impressive 18.71% since then. We note from Pliant Therapeutics Inc’s average daily trading volume that its 10-day average is 2.18 million shares, with the 3-month average coming to 2.52 million.
Pliant Therapeutics Inc stock received a consensus recommendation rating of Hold, based on a mean score of 2.69. If we narrow it down even further, the data shows that 0 out of 16 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 11 recommended PLRX as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Pliant Therapeutics Inc is expected to report earnings per share of -0.75 for the current quarter.
Pliant Therapeutics Inc (NASDAQ:PLRX) trade information
Instantly PLRX has showed a red trend with a performance of -1.90% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 1.7750 on recent trading dayincreased the stock’s daily price by 12.68%. The company’s shares are currently down -88.23% year-to-date, but still up 0.65% over the last five days. On the other hand, Pliant Therapeutics Inc (NASDAQ:PLRX) is -48.50% down in the 30-day period. We can see from the shorts that 3.29 million shares have been sold at a short interest cover period of 0.93 day(s).
The consensus price target as assigned by Wall Street analysts is $2.5, which translates to bulls needing to increase their stock price by 38.0% from its current value. Analyst projections state that PLRX is forecast to be at a low of $2 and a high of $3.
Forecasts for the next quarter put sales growth at 0.00%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -78.30%. Pliant Therapeutics Inc earnings are expected to increase by 23.99% in 2025, but the outlook is positive 16.00% per year for the next five years.
PLRX Dividends
Pliant Therapeutics Inc’s next quarterly earnings report is expected to be released on 2025-Mar-02.
Pliant Therapeutics Inc (NASDAQ:PLRX)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.27% of Pliant Therapeutics Inc shares, and 117.06% of them are in the hands of institutional investors. The stock currently has a share float of 121.02%. Pliant Therapeutics Inc stock is held by 236.0 institutions, with DEEP TRACK CAPITAL, LP being the largest institutional investor. By 2024-06-30, it held 9.8907% of the shares, which is about 5.97 million shares worth $64.2 million.
BLACKROCK INC., with 8.2612% or 4.97 million shares worth $53.45 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
